The deep tech and life sciences VC investment group EMV Capital has announced a successful fundraising for its portfolio company Wanda Health, along with an update on the company's commercial progress and market outlook.
The deep tech and life sciences VC investment group has issued new shares to directors and a PDMR, and certain directors have purchased additional shares.
The asset management firm has announced a change in shareholding by one of its directors.
The deep tech and life sciences VC investment group is expanding its senior finance leadership team with the appointment of a new Group CFO and the creation of a Portfolio CFO role.
The venture capital firm is hosting a virtual event to provide investors with insights into two of its portfolio companies.
The venture capital firm reported a challenging first half of 2025, with decreased revenue and a significant drop in cash position amid persistent market headwinds and limited capital availability.
The venture capital firm has acquired the assets of a novel antibiotic platform from a company in liquidation, with the potential to develop a product that could address the growing threat of antimicrobial resistance.
The venture capital firm will release its interim results on 30 September and hold an online investor presentation the same day.
The venture capital firm has entered into a licence agreement to share office space with a company owned by a substantial shareholder.
The asset management firm has announced changes to its major shareholdings.